By Tess Stynes
Zimmer Holdings Inc. said it submitted a revised proposal to European antitrust regulators to address concerns about its pending $13.35 billion acquisition of fellow orthopedic-device maker Biomet Inc.
Zimmer said the revised proposal is "generally consistent" with one it submitted in December, which included plans to divest itself of some assets in Europe.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.